Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation

R. H. Collins, L. A. Pineiro, E. D. Agura, J. W. Fay

Research output: Contribution to journalArticlepeer-review

33 Scopus citations


T prolymphocytic leukemia (T-PLL) is an unusual disease characterized by high white cell counts, older age at presentation, splenomegaly and a very aggressive clinical course. We describe a 47-year-old male with refractory T-PLL, who was treated with high-dose chemoradiotherapy and allogeneic bone marrow transplantation (BMT) from an HLA-matched sibling. The transplant was complicated by both acute and chronic graft-versus-host disease (GVHD). The patient achieved complete remission and remains in remission 3 years after the transplant.

Original languageEnglish (US)
Pages (from-to)627-628
Number of pages2
JournalBone Marrow Transplantation
Issue number6
StatePublished - 1998


  • Allogeneic bone marrow transplantation
  • T prolymphocytic leukemia

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'Treatment of T prolymphocytic leukemia with allogeneic bone marrow transplantation'. Together they form a unique fingerprint.

Cite this